THE ACTION OF BAY U-3405, A SPECIFIC THROMBOXANE (TX) A2 ANTAGONIST, IN MODELS OF THROMBOEMBOLISM AND SUDDEN-DEATH

被引：0
|
作者：
PERZBORN, E [1 ]
SEUTER, F [1 ]
机构：
[1] BAYER AG,INST PHARMACOL,W-5600 WUPPERTAL 1,GERMANY
来源：
THROMBOSIS AND HAEMOSTASIS | 1991年 / 65卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1178 / 1178
页数：1
相关论文
共 34 条
  • [1] EFFECT OF BAY-U3405, A NEW THROMBOXANE ANTAGONIST, ON SUDDEN-DEATH IN RABBITS
    SEUTER, F
    PERZBORN, E
    FIEDLER, VB
    ROSENTRETER, U
    BOSHAGEN, H
    JOURNAL OF LIPID MEDIATORS, 1991, 3 (03): : 283 - 288
  • [2] MECHANISM OF THE PROTECTIVE ACTION OF BAY-U-3405, A NEW SPECIFIC THROMBOXANE RECEPTOR ANTAGONIST, IN ARACHIDONATE-INDUCED SUDDEN-DEATH
    MA, XL
    KARASAWA, A
    LEFER, AM
    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 1991, 13 (02): : 105 - 110
  • [3] INHIBITION OF PLATELET-AGGREGATION BY A NOVEL THROMBOXANE ANTAGONIST BAY U-3405
    SEUTER, F
    PERZBORN, E
    FIEDLER, VB
    ROSENTRETER, U
    BOSHAGEN, H
    THROMBOSIS AND HAEMOSTASIS, 1989, 62 (01) : 112 - 112
  • [4] IN-VIVO INHIBITION OF PLATELET-AGGREGATION IN PATIENTS WITH SEVERE LIMB ARTERIOPATHY TREATED WITH BAY U-3405, A SPECIFIC TX A2 RECEPTOR ANTAGONIST
    BELLUCCI, S
    KEDRA, A
    MOLHOSABATIER, P
    ANDREASSIAN, B
    TOBELEM, G
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 639 - 639
  • [5] CHARACTERIZATION OF BAY-U-3405, A NOVEL THROMBOXANE A2 ENDOPEROXIDE RECEPTOR ANTAGONIST
    PERZBORN, E
    FIEDLER, VB
    SEUTER, F
    STASCH, JP
    WEBER, H
    SANDER, E
    BOSHAGEN, H
    ROSENTRETER, U
    STROKE, 1990, 21 (12) : 143 - 145
  • [6] EFFECT OF A NEW THROMBOXANE ANTAGONIST, BAY U-3405, ON PLATELET-FUNCTION IN PATIENTS WITH PERIPHERAL VASCULAR-DISEASE
    RIAMBAU, V
    DECASTELLARNAU, C
    GARCIA, C
    GONZALEZ, O
    ALBORS, M
    VIVER, E
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 1321 - 1321
  • [7] EFFECT OF BAY-U-3405, A NEW THROMBOXANE ANTAGONIST, ON COLLAGEN-INDUCED THROMBOEMBOLISM IN RABBITS
    SEUTER, F
    PERZBORN, E
    FIEDLER, VB
    STROKE, 1990, 21 (12) : 146 - 148
  • [8] BINDING CHARACTERISTICS OF THE NEW THROMBOXANE A2 PROSTAGLANDIN H-2-RECEPTOR ANTAGONIST [3H]BAY U-3405 TO WASHED HUMAN PLATELETS AND PLATELET MEMBRANES
    THEIS, JGW
    DELLWEG, H
    PERZBORN, E
    GROSS, R
    BIOCHEMICAL PHARMACOLOGY, 1992, 44 (03) : 495 - 503
  • [9] EFFECT OF BAY-U-3405, A NEW THROMBOXANE ANTAGONIST, ON ARACHIDONIC-ACID INDUCED THROMBOEMBOLISM
    SEUTER, F
    PERZBORN, E
    FIEDLER, VB
    ADVANCES IN PROSTAGLANDIN THROMBOXANE AND LEUKOTRIENE RESEARCH, 1991, 21 : 355 - 358
  • [10] BAY u3405, a thromboxane A(2) antagonist, reduces bronchial hyperresponsiveness in asthmatics
    Aizawa, H
    Shigyo, M
    Nogami, H
    Hirose, T
    Hara, N
    CHEST, 1996, 109 (02) : 338 - 342
1234